✦ LIBER ✦
Cost Analysis Of Treatment Success To Achieve A Clinically Relevant Composite Endpoint For Patients With Type-2 Diabetes On Liraglutide Or Other Antidiabetic Therapies In A Chinese Setting
✍ Scribed by Shi, L.W.; HAN, S.; Ploug, U.J.; LIU, F.
- Book ID
- 122228783
- Publisher
- John Wiley and Sons
- Year
- 2013
- Tongue
- English
- Weight
- 89 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.